Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-01-01 Smith W Bradford CFO & Treasurer Exercise or conversion · Restricted Stock Units −6,600 13,400
2022-01-01 Kelly Timothy P Chief Operating Officer Exercise or conversion +3,630 3,630
2022-01-01 Kelly Timothy P Chief Operating Officer Exercise or conversion · Restricted Stock Units −3,630 7,370
2022-01-01 Seymour Albert Chief Scientific Officer Exercise or conversion +4,290 133,307
2022-01-01 Seymour Albert Chief Scientific Officer Exercise or conversion · Restricted Stock Units −4,290 8,710
2022-01-01 Cohn Gabriel Chief Medical Officer Exercise or conversion +4,290 4,290
2022-01-01 Cohn Gabriel Chief Medical Officer Exercise or conversion · Restricted Stock Units −4,290 8,710
2022-01-01 TZIANABOS ARTHUR President & CEO Exercise or conversion +13,860 91,365
2022-01-01 TZIANABOS ARTHUR President & CEO Exercise or conversion · Restricted Stock Units −13,860 28,140
2021-09-03 Kelly Timothy P Sale −54 $7.70 $416 0
2021-06-17 Gregory Richard J. Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-06-17 PARMAR KUSH Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-06-17 Patterson Matthew R Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-06-17 REICIN ALISE Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-06-17 Poulton Jeffrey V. Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-06-17 Thistle Mary Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-06-17 GILLIS STEVEN Director Grant or award · Option (Right to Buy) +18,000 18,000
2021-04-07 Kelly Timothy P Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2021-03-01 Kelly Timothy P Sale −6,232 $11.16 $70K 0
2021-03-01 Kelly Timothy P Exercise or conversion +2,000 $6.63 $13K 4,232

Page 14 of 25 · 492 trades